BeyondSpring (BYSI) Market Capitalization (2017 - 2026)
BeyondSpring's (BYSI) quarterly Market Capitalization came in at $72.0 million in Q2 2026, down 24.06% year-over-year from $94.8 million in Q2 2025, and up 6.71% quarter-over-quarter from $67.4 million in Q1 2026.
Analysis
BeyondSpring (BYSI) Market Capitalization (2017 - 2026) Analysis & Trends
BeyondSpring has disclosed Market Capitalization across 10 years of filings, most recently posting $72.0 million for Q2 2026.
- In Q2 2026, Market Capitalization fell 24.06% year-over-year to $72.0 million; the TTM figure through Jun 2026 stood at $72.0 million (down 24.06% YoY), while the FY2025 annual figure was $67.0 million, up 2.0% from the prior year.
- Market Capitalization came in at $72.0 million for Q2 2026 at BeyondSpring, up from $67.4 million in the prior quarter.
- In the past five years, Market Capitalization ranged from a high of $139.3 million in Q1 2024 to a low of $35.1 million in Q4 2023.
- Average Market Capitalization over 5 years is $74.0 million, with a median of $69.7 million recorded in 2026.
- Year-over-year, Market Capitalization sank 82.09% in 2022 and jumped 110.17% in 2024.
- Over 5 years, Market Capitalization stood at $73.3 million in 2022, then plunged by 52.09% to $35.1 million in 2023, then soared by 87.08% to $65.7 million in 2024, then increased by 2.0% to $67.0 million in 2025, then increased by 7.36% to $72.0 million in 2026.
- Per Business Quant data, the three most recent Market Capitalization figures were $72.0 million in Q2 2026, $67.4 million in Q1 2026, and $67.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.96 Mn |
| Mar 31, 2026 | 67.44 Mn |
| Dec 31, 2025 | 67.03 Mn |
| Sep 30, 2025 | 72.98 Mn |
| Jun 30, 2025 | 94.76 Mn |
| Mar 31, 2025 | 57.85 Mn |
| Dec 31, 2024 | 65.72 Mn |
| Sep 30, 2024 | 92.29 Mn |
| Jun 30, 2024 | 96.72 Mn |
| Mar 31, 2024 | 139.33 Mn |
| Dec 31, 2023 | 35.13 Mn |
| Jun 30, 2023 | 46.02 Mn |
| Dec 31, 2022 | 73.32 Mn |
| Jun 30, 2022 | 56.06 Mn |
| Dec 31, 2021 | 176.34 Mn |
| Sep 30, 2021 | 472.55 Mn |
| Jun 30, 2021 | 313.04 Mn |
| Mar 31, 2021 | 331.93 Mn |
| Dec 31, 2020 | 365.81 Mn |
| Sep 30, 2020 | 371.16 Mn |